Cision PR Newswire

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....

APP Group Reinforces Support for Thailand’s Sustainability Initiatives

JAKARTA, Indonesia, April 10, 2025 /PRNewswire/ -- APP Group reaffirms its commitment to environmental responsibility by supporting Thailand's sustainability initiatives, including the country's January...

ChipMOS REPORTS YoY REVENUE INCREASE OF 5.1% IN MARCH 2025 AND 2.1% IN 1Q25 REVENUE

HSINCHU, April 10, 2025 /PRNewswire/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider...

Medtec Southeast Asia 2025 – The Southeast Asia’s Premier Medical Device Design & Manufacturing Exhibition Debuts in Malaysia

KUALA LUMPUR, Malaysia, April 10, 2025 /PRNewswire/ -- Informa Markets announces the launch of Medtec Southeast Asia 2025, the premier medical device design and...

SOAK UP CITY VIBES WITH EXCLUSIVE OFFERS AT FOUR SEASONS HOTEL SHENZHEN

Immerse in a buzzing modern metropolis SHENZHEN, China, April 10, 2025 /PRNewswire/ -- An inspiring city retreat awaits at Four Seasons Hotel Shenzhen, an...